Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

663
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
663
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

221
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
221
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

7.1K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
7.1K
Lipid Absorption01:24

Lipid Absorption

3.0K
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
3.0K
Variability: Analysis01:11

Variability: Analysis

570
Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
570
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

5.9K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
5.9K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Head Acceleration Event Exposure during Pre-Season Training in Elite Men's Rugby Union.

Sports medicine - open·2026
Same author

What are healthcare practitioners' perspectives and experiences of strength assessment and strength training practices in community pulmonary rehabilitation? A qualitative study from the UK.

BMJ open·2026
Same author

Metabolic state determines the brain and direct islet effects of liraglutide on enhanced insulin secretion.

Diabetologia·2026
Same author

The Dark Tetrad and academic dishonesty: a systematic review and narrative synthesis of personality predictors of cheating, plagiarism, and deception in education.

BMC psychology·2026
Same author

Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment response.

bioRxiv : the preprint server for biology·2026
Same author

Improving social support among sports medicine practitioners: a call to action.

British journal of sports medicine·2026

関連する実験動画

Updated: Feb 23, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.6K

リポプロテインの個体内変動性 (a)

Lakshmi Lakkineni1, Matthew Waite2, Alessia David3

  • 1Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK (Lakkineni, Waite, Dr Jones, and Dr Cegla).

Journal of clinical lipidology
|February 21, 2026
PubMed
まとめ

リポプロテイン (a) [Lp (a) ]の検査を繰り返すことは,個体内での変動がしばしば研究室の基準を超えているため,通常不要です. しかし,リスクの値に近い患者を対象にLp (a) 検査を繰り返すか,Lp (a) を低下させる治療を検討することを検討してください.

キーワード:
心血管疾患のリスク変数係数が変化する.ディスリピデミアミア (Dyslipidaemia) とはイントラ個体による変動.リポプロテイン (a)(a) Lp (a) について

さらに関連する動画

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.8K
High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

480

関連する実験動画

Last Updated: Feb 23, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.6K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.8K
High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

480

科学分野:

  • 心血管医学は,心臓血管医学である.
  • 臨床化学 臨床化学について
  • 実験室医学は,研究室医学である.

背景:

  • リポプロテイン (Lp) は,動脈硬化性心血管疾患の重要な独立リスク因子である.
  • Lp (a) レベルは一般的に安定していますが,個体内での変動の程度と再検査の必要性は不明です.

研究 の 目的:

  • Lp (a) レベルにおける個体内変動を評価する.
  • 心血管リスク分類に対するリピートLp (a) テストの臨床的影響を評価する.

主な方法:

  • 少なくとも2つのLp (a) 測定値を有する250人の患者の遡及的分析.
  • 測定は,第三次医療の脂質クリニックで,平均17.1 ± 15.5ヶ月間にわたって行われました.

主要な成果:

  • Lp (a) の個体内変動係数 (CV) は,実験室の基準を超えました.
  • 心血管疾患のリスク再分類は,12.4% (NLAの値) と6.8% (ESCの値) で発生しました.
  • 変性は,検査,薬剤,または生化学的パラメータの間の時間と関連付けられませんでした.

結論:

  • 繰り返す Lp (a) 検査は一般的に必要ありません.
  • リスクの値に近い個体や,Lp (a) を低下させる治療のために評価された個体に対する再検査を検討してください.